Anti-VEGF Drug Showing Promise for Diabetic Macular Edema

In a phase II study of patients with diabetic macular edema (DME), intravitreal injections of a fusion protein called VEGF Trap-Eye proved superior to focal/grid laser treatment, researchers report.
Reuters Health Information

Full Story →